Literature DB >> 7372646

Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat.

E Windler, Y Chao, R J Havel.   

Abstract

The uptake and metabolism of lymphatic large chylomicrons from fat-fed rats, lymphatic small chylomicrons from glucose-fed rats, and hepatic very low density lipoproteins from perfusates of isolated livers, and of remnants produced from these lipoproteins in functionally eviscerated rats were studied in the isolated perfused rat liver. All lipoproteins were labeled isotopically in their cholesteryl ester and triglyceride moieties. Uptake of the labeled lipids or large chylomicrons was slow and limited, but these lipids in small chylomicrons and hepatic very low density lipoproteins were taken up and metabolized progressively and at equal rates. Incubation with very low density lipoprotein-free plasma increased the content of C apolipoproteins in small chylomicrons and hepatic very low density lipoproteins and greatly retarded the hepatic uptake of their labeled lipids. In remnants from all sources, which are depleted of C apolipoproteins but not of apolipoprotein E, the labeled lipids were rapidly taken up and metabolized. Neither extensive hydrolysis of core triglycerides nor the production of monoglycerides was required for this rapid hepatic uptake. These results are consistent with the hypothesis that one or more of the C apolipoproteins opposes and apolipoprotein E promotes recognition of triglyceride-rich lipoproteins by a hepatic receptor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7372646

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects.

Authors:  D C Rubinsztein; J C Cohen; G M Berger; D R van der Westhuyzen; G A Coetzee; W Gevers
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

2.  Uptake and degradation of filamentous actin and vitamin D-binding protein in the rat.

Authors:  S Dueland; M S Nenseter; C A Drevon
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

3.  Chylomicron remnant and asialoglycoprotein metabolism are independent.

Authors:  A D Cooper; D Coleman
Journal:  Lipids       Date:  1985-10       Impact factor: 1.880

4.  Uptake of artificial model remnant lipoprotein emulsions by the perfused rat liver.

Authors:  T G Redgrave; R C Maranhao; A M Tercyak; E C Lincoln; H Brunengraber
Journal:  Lipids       Date:  1988-02       Impact factor: 1.880

5.  Chylomicron-remnant uptake by freshly isolated hepatocytes. Effect of heparin and of hepatic triacylglycerol lipase.

Authors:  F Sultan; D Lagrange; X Le Liepvre; S Griglio
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

6.  Regulation of serum apolipoprotein E metabolism: role of chylomicron metabolism.

Authors:  J G DeLamatre; B R Krause; P S Roheim
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

7.  Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor.

Authors:  J Herz; S Q Qiu; A Oesterle; H V DeSilva; S Shafi; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

8.  Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.

Authors:  E S Krul; M J Tikkanen; T G Cole; J M Davie; G Schonfeld
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

9.  Independent regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and chylomicron remnant receptor activities in rat liver.

Authors:  D P Wade; A K Soutar; G F Gibbons
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

10.  Influence of lysophosphatidylcholine on the C-apolipoprotein content of rat and human triglyceride-rich lipoproteins during triglyceride hydrolysis.

Authors:  E E Windler; S Preyer; H Greten
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.